Developer of antibody-drug conjugates designed for the treatment of multiple diseases. The company's conjugates use protein conjugation technology that allows the attachment of any two proteins togeth...

Healthcare
Berkeley, CA, United States
Founded 2020
10 employees
Website
Valuation
$0
Share Price
N/A
Total Raised
$9.1M
Last Round
N/A

Get the full picture

Create a free account to unlock CatenaBio's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required